FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Published:2020-11 Issue:11 Volume:26 Page:2165-2173
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Rodríguez-Arbolí Eduardo,Labopin Myriam,Tischer Johanna,Brecht Arne,Ganser Arnold,Finke Jürgen,Blau Igor Wolfgang,Kröger Nicolaus,Kalhs Peter,Forcade Edouard,Bunjes Donald,Spyridonidis Alexandros,Savani Bipin,Nagler Arnon,Mohty Mohamad

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference47 articles.

1. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century;Pulte;Haematologica,2008

2. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia;Schlenk;N Engl J Med,2008

3. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European leukemiaNet recommendations: evaluation of the proposed reporting system;Röllig;J Clin Oncol,2011

4. Acute myeloid leukemia (AML): different treatment strategies versus a common standard arm—combined prospective analysis by the German AML Intergroup;Büchner;J Clin Oncol,2012

5. Improved outcome for AML patients over the years 2000-2014;Bertoli;Blood Cancer J,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study;Annals of Hematology;2024-09-07

2. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

3. Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2024-08-31

4. Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia;British Journal of Haematology;2024-06-04

5. Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia;Transplant Immunology;2024-06